otricath
Houston
About otricath
The Otricath™ introduces a new perspective on therapy delivery. The platform technology delivers cancer-fighting agents to solid tumors with unparalleled control, predictability, and safety for optimal therapeutic benefit and minimal systemic toxicity.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $35.0K
- Last round: Grant (May 2017)
- Website: otricath.com
- Phone: (713)839-8600
Industries & Categories
Biotechnology, Delivery, Health Care
Social Profiles
Canonical: https://fsome.com/organization/otricath-2228853 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.